LifeMine Therapeutics
PrivateLast Round
Series D
and E
Aug 6, 2026
Total Funding Raised
$558M
Company Overview
LifeMine Therapeutics is a biotechnology company that leverages evolutionary insights from fungi to discover and develop novel precision medicines.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LifeMine Therapeutics Comparables
Compare LifeMine Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hexagon Bio | 79% | |
| Sirenas Marine Discovery | 79% | |
| Enveda Biosciences | 77% | |
LifeMine Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D and E | Aug 6, 2026 | ||||
| Series C | Mar 23, 2022 | ||||
| Series B | Jan 7, 2021 | ||||
| Series A | Sep 18, 2017 |
Key People
Founding team and executive leadership
LifeMine Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series A |
| RA Capital Management | Series D and E |
| GV | Series C, Series A, Series D and E, Series B |
| Blue Pool Capital | Series C, Series A, Series B |
| ARCH Venture Partners | Series C, Series A, Series D and E, Series B |
| Bezos Expeditions | Series D and E |
| Fidelity Management & Research Company | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2022
$175M round led by Fidelity Management & Research Company.
- Jan 7, 2021
$50M round led by Milky Way Cap and Richard Klausner.
LifeMine Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LifeMine Therapeutics's valuation, stock price, and market status.